1Coté TR,Biggar RJ,Rosenberg PS,et al.Non-Hodgkin's lymphoma among people with AIDS:incidence,presentation and public health burden.AIDS/Cancer Study Group.Int J Cancer,1997,73:645-650.
2Polesel J,Clifford GM,Rickenbach M,et al.Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.AIDS,2008,22:301-306.
3Carbone A,Cesarman E,Spina M,et al.HIV-associated lymphomas and gamma-herpesviruses.Blood,2009,113:1213-1224.
5Sparano JA,Hu X,Wiernik PH,et al.Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin' s lymphoma treated with chemotherapy.J Natl Cancer Inst,1997,89:301-307.
6Collaboration of Observational HIV Epidemiological Research Europe(COHERE)study group,Bohlius J,Schmidlin K,et al.Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy.AIDS,2009,23:2029-2037.
7Sparano JA.HIV-associated lymphoma:the evidence for treating aggressively but with caution.Curr Opin Oncol,2007,19:458-463.
8Sparano JA,Lee JY,Kaplan LD,et al.Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.Blood,2010,115:3008-3016.
9Re A,Michieli M,Casari S,et al.High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma:long-term results of the Italian Cooperative Group on AIDS and Tumors(GICAT)study with analysis of prognostic factors.Blood,2009,114:1306-1313.
